Global Gastrointestinal Therapeutics and Diagnostics Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Gastrointestinal disorders are related to digestive system and generally affect the colon, small & large intestine and rectum. The disorders include constipation, peptic ulcer diseases and irritable bowel syndrome. The major reason and cause of GI disorders are stress, intake of medicines such as iron pills and anti-depressants and unhealthy eating habits. Symptoms of the gastrointestinal infections include pain, bloating, diarrhea, nausea and vomiting. The major drugs that dominate the gastrointestinal diagnostics and therapeutics market are aciphex, afinitor, akynzeo, dificid and Prilosec.
LPI (LP Information)' newest research report, the “Gastrointestinal Therapeutics and Diagnostics Industry Forecast” looks at past sales and reviews total world Gastrointestinal Therapeutics and Diagnostics sales in 2022, providing a comprehensive analysis by region and market sector of projected Gastrointestinal Therapeutics and Diagnostics sales for 2023 through 2029. With Gastrointestinal Therapeutics and Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gastrointestinal Therapeutics and Diagnostics industry.
This Insight Report provides a comprehensive analysis of the global Gastrointestinal Therapeutics and Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Gastrointestinal Therapeutics and Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Gastrointestinal Therapeutics and Diagnostics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gastrointestinal Therapeutics and Diagnostics and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gastrointestinal Therapeutics and Diagnostics.
The global Gastrointestinal Therapeutics and Diagnostics market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Gastrointestinal Therapeutics and Diagnostics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Gastrointestinal Therapeutics and Diagnostics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Gastrointestinal Therapeutics and Diagnostics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Gastrointestinal Therapeutics and Diagnostics players cover Abbott Laboratories, AstraZeneca, Eisai, Johnson & Johnson, Salix Pharmaceuticals and Takeda Pharmaceutical Company, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Gastrointestinal Therapeutics and Diagnostics market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Gastrointestinal disorders are related to digestive system and generally affect the colon, small & large intestine and rectum. The disorders include constipation, peptic ulcer diseases and irritable bowel syndrome. The major reason and cause of GI disorders are stress, intake of medicines such as iron pills and anti-depressants and unhealthy eating habits. Symptoms of the gastrointestinal infections include pain, bloating, diarrhea, nausea and vomiting. The major drugs that dominate the gastrointestinal diagnostics and therapeutics market are aciphex, afinitor, akynzeo, dificid and Prilosec.
LPI (LP Information)' newest research report, the “Gastrointestinal Therapeutics and Diagnostics Industry Forecast” looks at past sales and reviews total world Gastrointestinal Therapeutics and Diagnostics sales in 2022, providing a comprehensive analysis by region and market sector of projected Gastrointestinal Therapeutics and Diagnostics sales for 2023 through 2029. With Gastrointestinal Therapeutics and Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gastrointestinal Therapeutics and Diagnostics industry.
This Insight Report provides a comprehensive analysis of the global Gastrointestinal Therapeutics and Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Gastrointestinal Therapeutics and Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Gastrointestinal Therapeutics and Diagnostics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gastrointestinal Therapeutics and Diagnostics and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gastrointestinal Therapeutics and Diagnostics.
The global Gastrointestinal Therapeutics and Diagnostics market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Gastrointestinal Therapeutics and Diagnostics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Gastrointestinal Therapeutics and Diagnostics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Gastrointestinal Therapeutics and Diagnostics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Gastrointestinal Therapeutics and Diagnostics players cover Abbott Laboratories, AstraZeneca, Eisai, Johnson & Johnson, Salix Pharmaceuticals and Takeda Pharmaceutical Company, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Gastrointestinal Therapeutics and Diagnostics market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Diagnostics
- Therapeutics
- Gastroenteritis
- GI Bleeding
- Irritable Bowel Syndrome
- Peptic Ulcer Disease (PUD)
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Abbott Laboratories
- AstraZeneca
- Eisai
- Johnson & Johnson
- Salix Pharmaceuticals
- Takeda Pharmaceutical Company
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Gastrointestinal Therapeutics and Diagnostics Market Size 2018-2029
2.1.2 Gastrointestinal Therapeutics and Diagnostics Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Gastrointestinal Therapeutics and Diagnostics Segment by Type
2.2.1 Diagnostics
2.2.2 Therapeutics
2.3 Gastrointestinal Therapeutics and Diagnostics Market Size by Type
2.3.1 Gastrointestinal Therapeutics and Diagnostics Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Type (2018-2023)
2.4 Gastrointestinal Therapeutics and Diagnostics Segment by Application
2.4.1 Gastroenteritis
2.4.2 GI Bleeding
2.4.3 Irritable Bowel Syndrome
2.4.4 Peptic Ulcer Disease (PUD)
2.4.5 Others
2.5 Gastrointestinal Therapeutics and Diagnostics Market Size by Application
2.5.1 Gastrointestinal Therapeutics and Diagnostics Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Application (2018-2023)
3 GASTROINTESTINAL THERAPEUTICS AND DIAGNOSTICS MARKET SIZE BY PLAYER
3.1 Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Players
3.1.1 Global Gastrointestinal Therapeutics and Diagnostics Revenue by Players (2018-2023)
3.1.2 Global Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Players (2018-2023)
3.2 Global Gastrointestinal Therapeutics and Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 GASTROINTESTINAL THERAPEUTICS AND DIAGNOSTICS BY REGIONS
4.1 Gastrointestinal Therapeutics and Diagnostics Market Size by Regions (2018-2023)
4.2 Americas Gastrointestinal Therapeutics and Diagnostics Market Size Growth (2018-2023)
4.3 APAC Gastrointestinal Therapeutics and Diagnostics Market Size Growth (2018-2023)
4.4 Europe Gastrointestinal Therapeutics and Diagnostics Market Size Growth (2018-2023)
4.5 Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2018-2023)
5.2 Americas Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2018-2023)
5.3 Americas Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gastrointestinal Therapeutics and Diagnostics Market Size by Region (2018-2023)
6.2 APAC Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2018-2023)
6.3 APAC Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Gastrointestinal Therapeutics and Diagnostics by Country (2018-2023)
7.2 Europe Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2018-2023)
7.3 Europe Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Gastrointestinal Therapeutics and Diagnostics by Region (2018-2023)
8.2 Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2018-2023)
8.3 Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL GASTROINTESTINAL THERAPEUTICS AND DIAGNOSTICS MARKET FORECAST
10.1 Global Gastrointestinal Therapeutics and Diagnostics Forecast by Regions (2024-2029)
10.1.1 Global Gastrointestinal Therapeutics and Diagnostics Forecast by Regions (2024-2029)
10.1.2 Americas Gastrointestinal Therapeutics and Diagnostics Forecast
10.1.3 APAC Gastrointestinal Therapeutics and Diagnostics Forecast
10.1.4 Europe Gastrointestinal Therapeutics and Diagnostics Forecast
10.1.5 Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Forecast
10.2 Americas Gastrointestinal Therapeutics and Diagnostics Forecast by Country (2024-2029)
10.2.1 United States Gastrointestinal Therapeutics and Diagnostics Market Forecast
10.2.2 Canada Gastrointestinal Therapeutics and Diagnostics Market Forecast
10.2.3 Mexico Gastrointestinal Therapeutics and Diagnostics Market Forecast
10.2.4 Brazil Gastrointestinal Therapeutics and Diagnostics Market Forecast
10.3 APAC Gastrointestinal Therapeutics and Diagnostics Forecast by Region (2024-2029)
10.3.1 China Gastrointestinal Therapeutics and Diagnostics Market Forecast
10.3.2 Japan Gastrointestinal Therapeutics and Diagnostics Market Forecast
10.3.3 Korea Gastrointestinal Therapeutics and Diagnostics Market Forecast
10.3.4 Southeast Asia Gastrointestinal Therapeutics and Diagnostics Market Forecast
10.3.5 India Gastrointestinal Therapeutics and Diagnostics Market Forecast
10.3.6 Australia Gastrointestinal Therapeutics and Diagnostics Market Forecast
10.4 Europe Gastrointestinal Therapeutics and Diagnostics Forecast by Country (2024-2029)
10.4.1 Germany Gastrointestinal Therapeutics and Diagnostics Market Forecast
10.4.2 France Gastrointestinal Therapeutics and Diagnostics Market Forecast
10.4.3 UK Gastrointestinal Therapeutics and Diagnostics Market Forecast
10.4.4 Italy Gastrointestinal Therapeutics and Diagnostics Market Forecast
10.4.5 Russia Gastrointestinal Therapeutics and Diagnostics Market Forecast
10.5 Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Forecast by Region (2024-2029)
10.5.1 Egypt Gastrointestinal Therapeutics and Diagnostics Market Forecast
10.5.2 South Africa Gastrointestinal Therapeutics and Diagnostics Market Forecast
10.5.3 Israel Gastrointestinal Therapeutics and Diagnostics Market Forecast
10.5.4 Turkey Gastrointestinal Therapeutics and Diagnostics Market Forecast
10.5.5 GCC Countries Gastrointestinal Therapeutics and Diagnostics Market Forecast
10.6 Global Gastrointestinal Therapeutics and Diagnostics Forecast by Type (2024-2029)
10.7 Global Gastrointestinal Therapeutics and Diagnostics Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Information
11.1.2 Abbott Laboratories Gastrointestinal Therapeutics and Diagnostics Product Offered
11.1.3 Abbott Laboratories Gastrointestinal Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Abbott Laboratories Main Business Overview
11.1.5 Abbott Laboratories Latest Developments
11.2 AstraZeneca
11.2.1 AstraZeneca Company Information
11.2.2 AstraZeneca Gastrointestinal Therapeutics and Diagnostics Product Offered
11.2.3 AstraZeneca Gastrointestinal Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 AstraZeneca Main Business Overview
11.2.5 AstraZeneca Latest Developments
11.3 Eisai
11.3.1 Eisai Company Information
11.3.2 Eisai Gastrointestinal Therapeutics and Diagnostics Product Offered
11.3.3 Eisai Gastrointestinal Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Eisai Main Business Overview
11.3.5 Eisai Latest Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Information
11.4.2 Johnson & Johnson Gastrointestinal Therapeutics and Diagnostics Product Offered
11.4.3 Johnson & Johnson Gastrointestinal Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Johnson & Johnson Main Business Overview
11.4.5 Johnson & Johnson Latest Developments
11.5 Salix Pharmaceuticals
11.5.1 Salix Pharmaceuticals Company Information
11.5.2 Salix Pharmaceuticals Gastrointestinal Therapeutics and Diagnostics Product Offered
11.5.3 Salix Pharmaceuticals Gastrointestinal Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Salix Pharmaceuticals Main Business Overview
11.5.5 Salix Pharmaceuticals Latest Developments
11.6 Takeda Pharmaceutical Company
11.6.1 Takeda Pharmaceutical Company Company Information
11.6.2 Takeda Pharmaceutical Company Gastrointestinal Therapeutics and Diagnostics Product Offered
11.6.3 Takeda Pharmaceutical Company Gastrointestinal Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Takeda Pharmaceutical Company Main Business Overview
11.6.5 Takeda Pharmaceutical Company Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Gastrointestinal Therapeutics and Diagnostics Market Size 2018-2029
2.1.2 Gastrointestinal Therapeutics and Diagnostics Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Gastrointestinal Therapeutics and Diagnostics Segment by Type
2.2.1 Diagnostics
2.2.2 Therapeutics
2.3 Gastrointestinal Therapeutics and Diagnostics Market Size by Type
2.3.1 Gastrointestinal Therapeutics and Diagnostics Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Type (2018-2023)
2.4 Gastrointestinal Therapeutics and Diagnostics Segment by Application
2.4.1 Gastroenteritis
2.4.2 GI Bleeding
2.4.3 Irritable Bowel Syndrome
2.4.4 Peptic Ulcer Disease (PUD)
2.4.5 Others
2.5 Gastrointestinal Therapeutics and Diagnostics Market Size by Application
2.5.1 Gastrointestinal Therapeutics and Diagnostics Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Application (2018-2023)
3 GASTROINTESTINAL THERAPEUTICS AND DIAGNOSTICS MARKET SIZE BY PLAYER
3.1 Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Players
3.1.1 Global Gastrointestinal Therapeutics and Diagnostics Revenue by Players (2018-2023)
3.1.2 Global Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Players (2018-2023)
3.2 Global Gastrointestinal Therapeutics and Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 GASTROINTESTINAL THERAPEUTICS AND DIAGNOSTICS BY REGIONS
4.1 Gastrointestinal Therapeutics and Diagnostics Market Size by Regions (2018-2023)
4.2 Americas Gastrointestinal Therapeutics and Diagnostics Market Size Growth (2018-2023)
4.3 APAC Gastrointestinal Therapeutics and Diagnostics Market Size Growth (2018-2023)
4.4 Europe Gastrointestinal Therapeutics and Diagnostics Market Size Growth (2018-2023)
4.5 Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2018-2023)
5.2 Americas Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2018-2023)
5.3 Americas Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gastrointestinal Therapeutics and Diagnostics Market Size by Region (2018-2023)
6.2 APAC Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2018-2023)
6.3 APAC Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Gastrointestinal Therapeutics and Diagnostics by Country (2018-2023)
7.2 Europe Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2018-2023)
7.3 Europe Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Gastrointestinal Therapeutics and Diagnostics by Region (2018-2023)
8.2 Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2018-2023)
8.3 Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL GASTROINTESTINAL THERAPEUTICS AND DIAGNOSTICS MARKET FORECAST
10.1 Global Gastrointestinal Therapeutics and Diagnostics Forecast by Regions (2024-2029)
10.1.1 Global Gastrointestinal Therapeutics and Diagnostics Forecast by Regions (2024-2029)
10.1.2 Americas Gastrointestinal Therapeutics and Diagnostics Forecast
10.1.3 APAC Gastrointestinal Therapeutics and Diagnostics Forecast
10.1.4 Europe Gastrointestinal Therapeutics and Diagnostics Forecast
10.1.5 Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Forecast
10.2 Americas Gastrointestinal Therapeutics and Diagnostics Forecast by Country (2024-2029)
10.2.1 United States Gastrointestinal Therapeutics and Diagnostics Market Forecast
10.2.2 Canada Gastrointestinal Therapeutics and Diagnostics Market Forecast
10.2.3 Mexico Gastrointestinal Therapeutics and Diagnostics Market Forecast
10.2.4 Brazil Gastrointestinal Therapeutics and Diagnostics Market Forecast
10.3 APAC Gastrointestinal Therapeutics and Diagnostics Forecast by Region (2024-2029)
10.3.1 China Gastrointestinal Therapeutics and Diagnostics Market Forecast
10.3.2 Japan Gastrointestinal Therapeutics and Diagnostics Market Forecast
10.3.3 Korea Gastrointestinal Therapeutics and Diagnostics Market Forecast
10.3.4 Southeast Asia Gastrointestinal Therapeutics and Diagnostics Market Forecast
10.3.5 India Gastrointestinal Therapeutics and Diagnostics Market Forecast
10.3.6 Australia Gastrointestinal Therapeutics and Diagnostics Market Forecast
10.4 Europe Gastrointestinal Therapeutics and Diagnostics Forecast by Country (2024-2029)
10.4.1 Germany Gastrointestinal Therapeutics and Diagnostics Market Forecast
10.4.2 France Gastrointestinal Therapeutics and Diagnostics Market Forecast
10.4.3 UK Gastrointestinal Therapeutics and Diagnostics Market Forecast
10.4.4 Italy Gastrointestinal Therapeutics and Diagnostics Market Forecast
10.4.5 Russia Gastrointestinal Therapeutics and Diagnostics Market Forecast
10.5 Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Forecast by Region (2024-2029)
10.5.1 Egypt Gastrointestinal Therapeutics and Diagnostics Market Forecast
10.5.2 South Africa Gastrointestinal Therapeutics and Diagnostics Market Forecast
10.5.3 Israel Gastrointestinal Therapeutics and Diagnostics Market Forecast
10.5.4 Turkey Gastrointestinal Therapeutics and Diagnostics Market Forecast
10.5.5 GCC Countries Gastrointestinal Therapeutics and Diagnostics Market Forecast
10.6 Global Gastrointestinal Therapeutics and Diagnostics Forecast by Type (2024-2029)
10.7 Global Gastrointestinal Therapeutics and Diagnostics Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Information
11.1.2 Abbott Laboratories Gastrointestinal Therapeutics and Diagnostics Product Offered
11.1.3 Abbott Laboratories Gastrointestinal Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Abbott Laboratories Main Business Overview
11.1.5 Abbott Laboratories Latest Developments
11.2 AstraZeneca
11.2.1 AstraZeneca Company Information
11.2.2 AstraZeneca Gastrointestinal Therapeutics and Diagnostics Product Offered
11.2.3 AstraZeneca Gastrointestinal Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 AstraZeneca Main Business Overview
11.2.5 AstraZeneca Latest Developments
11.3 Eisai
11.3.1 Eisai Company Information
11.3.2 Eisai Gastrointestinal Therapeutics and Diagnostics Product Offered
11.3.3 Eisai Gastrointestinal Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Eisai Main Business Overview
11.3.5 Eisai Latest Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Information
11.4.2 Johnson & Johnson Gastrointestinal Therapeutics and Diagnostics Product Offered
11.4.3 Johnson & Johnson Gastrointestinal Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Johnson & Johnson Main Business Overview
11.4.5 Johnson & Johnson Latest Developments
11.5 Salix Pharmaceuticals
11.5.1 Salix Pharmaceuticals Company Information
11.5.2 Salix Pharmaceuticals Gastrointestinal Therapeutics and Diagnostics Product Offered
11.5.3 Salix Pharmaceuticals Gastrointestinal Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Salix Pharmaceuticals Main Business Overview
11.5.5 Salix Pharmaceuticals Latest Developments
11.6 Takeda Pharmaceutical Company
11.6.1 Takeda Pharmaceutical Company Company Information
11.6.2 Takeda Pharmaceutical Company Gastrointestinal Therapeutics and Diagnostics Product Offered
11.6.3 Takeda Pharmaceutical Company Gastrointestinal Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Takeda Pharmaceutical Company Main Business Overview
11.6.5 Takeda Pharmaceutical Company Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Gastrointestinal Therapeutics and Diagnostics Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Diagnostics
Table 3. Major Players of Therapeutics
Table 4. Gastrointestinal Therapeutics and Diagnostics Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Type (2018-2023)
Table 7. Gastrointestinal Therapeutics and Diagnostics Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Application (2018-2023)
Table 10. Global Gastrointestinal Therapeutics and Diagnostics Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Player (2018-2023)
Table 12. Gastrointestinal Therapeutics and Diagnostics Key Players Head office and Products Offered
Table 13. Gastrointestinal Therapeutics and Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Gastrointestinal Therapeutics and Diagnostics Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Regions (2018-2023)
Table 18. Global Gastrointestinal Therapeutics and Diagnostics Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Country (2018-2023)
Table 22. Americas Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Type (2018-2023)
Table 24. Americas Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Application (2018-2023)
Table 26. APAC Gastrointestinal Therapeutics and Diagnostics Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Region (2018-2023)
Table 28. APAC Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Type (2018-2023)
Table 30. APAC Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Application (2018-2023)
Table 32. Europe Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Country (2018-2023)
Table 34. Europe Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Type (2018-2023)
Table 36. Europe Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Gastrointestinal Therapeutics and Diagnostics
Table 45. Key Market Challenges & Risks of Gastrointestinal Therapeutics and Diagnostics
Table 46. Key Industry Trends of Gastrointestinal Therapeutics and Diagnostics
Table 47. Global Gastrointestinal Therapeutics and Diagnostics Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Gastrointestinal Therapeutics and Diagnostics Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Gastrointestinal Therapeutics and Diagnostics Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Gastrointestinal Therapeutics and Diagnostics Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. Abbott Laboratories Details, Company Type, Gastrointestinal Therapeutics and Diagnostics Area Served and Its Competitors
Table 52. Abbott Laboratories Gastrointestinal Therapeutics and Diagnostics Product Offered
Table 53. Abbott Laboratories Gastrointestinal Therapeutics and Diagnostics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. Abbott Laboratories Main Business
Table 55. Abbott Laboratories Latest Developments
Table 56. AstraZeneca Details, Company Type, Gastrointestinal Therapeutics and Diagnostics Area Served and Its Competitors
Table 57. AstraZeneca Gastrointestinal Therapeutics and Diagnostics Product Offered
Table 58. AstraZeneca Main Business
Table 59. AstraZeneca Gastrointestinal Therapeutics and Diagnostics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. AstraZeneca Latest Developments
Table 61. Eisai Details, Company Type, Gastrointestinal Therapeutics and Diagnostics Area Served and Its Competitors
Table 62. Eisai Gastrointestinal Therapeutics and Diagnostics Product Offered
Table 63. Eisai Main Business
Table 64. Eisai Gastrointestinal Therapeutics and Diagnostics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Eisai Latest Developments
Table 66. Johnson & Johnson Details, Company Type, Gastrointestinal Therapeutics and Diagnostics Area Served and Its Competitors
Table 67. Johnson & Johnson Gastrointestinal Therapeutics and Diagnostics Product Offered
Table 68. Johnson & Johnson Main Business
Table 69. Johnson & Johnson Gastrointestinal Therapeutics and Diagnostics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. Johnson & Johnson Latest Developments
Table 71. Salix Pharmaceuticals Details, Company Type, Gastrointestinal Therapeutics and Diagnostics Area Served and Its Competitors
Table 72. Salix Pharmaceuticals Gastrointestinal Therapeutics and Diagnostics Product Offered
Table 73. Salix Pharmaceuticals Main Business
Table 74. Salix Pharmaceuticals Gastrointestinal Therapeutics and Diagnostics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. Salix Pharmaceuticals Latest Developments
Table 76. Takeda Pharmaceutical Company Details, Company Type, Gastrointestinal Therapeutics and Diagnostics Area Served and Its Competitors
Table 77. Takeda Pharmaceutical Company Gastrointestinal Therapeutics and Diagnostics Product Offered
Table 78. Takeda Pharmaceutical Company Main Business
Table 79. Takeda Pharmaceutical Company Gastrointestinal Therapeutics and Diagnostics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. Takeda Pharmaceutical Company Latest Developments
Table 1. Gastrointestinal Therapeutics and Diagnostics Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Diagnostics
Table 3. Major Players of Therapeutics
Table 4. Gastrointestinal Therapeutics and Diagnostics Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Type (2018-2023)
Table 7. Gastrointestinal Therapeutics and Diagnostics Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Application (2018-2023)
Table 10. Global Gastrointestinal Therapeutics and Diagnostics Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Player (2018-2023)
Table 12. Gastrointestinal Therapeutics and Diagnostics Key Players Head office and Products Offered
Table 13. Gastrointestinal Therapeutics and Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Gastrointestinal Therapeutics and Diagnostics Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Regions (2018-2023)
Table 18. Global Gastrointestinal Therapeutics and Diagnostics Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Country (2018-2023)
Table 22. Americas Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Type (2018-2023)
Table 24. Americas Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Application (2018-2023)
Table 26. APAC Gastrointestinal Therapeutics and Diagnostics Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Region (2018-2023)
Table 28. APAC Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Type (2018-2023)
Table 30. APAC Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Application (2018-2023)
Table 32. Europe Gastrointestinal Therapeutics and Diagnostics Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Country (2018-2023)
Table 34. Europe Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Type (2018-2023)
Table 36. Europe Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Gastrointestinal Therapeutics and Diagnostics
Table 45. Key Market Challenges & Risks of Gastrointestinal Therapeutics and Diagnostics
Table 46. Key Industry Trends of Gastrointestinal Therapeutics and Diagnostics
Table 47. Global Gastrointestinal Therapeutics and Diagnostics Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Gastrointestinal Therapeutics and Diagnostics Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Gastrointestinal Therapeutics and Diagnostics Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Gastrointestinal Therapeutics and Diagnostics Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. Abbott Laboratories Details, Company Type, Gastrointestinal Therapeutics and Diagnostics Area Served and Its Competitors
Table 52. Abbott Laboratories Gastrointestinal Therapeutics and Diagnostics Product Offered
Table 53. Abbott Laboratories Gastrointestinal Therapeutics and Diagnostics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. Abbott Laboratories Main Business
Table 55. Abbott Laboratories Latest Developments
Table 56. AstraZeneca Details, Company Type, Gastrointestinal Therapeutics and Diagnostics Area Served and Its Competitors
Table 57. AstraZeneca Gastrointestinal Therapeutics and Diagnostics Product Offered
Table 58. AstraZeneca Main Business
Table 59. AstraZeneca Gastrointestinal Therapeutics and Diagnostics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. AstraZeneca Latest Developments
Table 61. Eisai Details, Company Type, Gastrointestinal Therapeutics and Diagnostics Area Served and Its Competitors
Table 62. Eisai Gastrointestinal Therapeutics and Diagnostics Product Offered
Table 63. Eisai Main Business
Table 64. Eisai Gastrointestinal Therapeutics and Diagnostics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Eisai Latest Developments
Table 66. Johnson & Johnson Details, Company Type, Gastrointestinal Therapeutics and Diagnostics Area Served and Its Competitors
Table 67. Johnson & Johnson Gastrointestinal Therapeutics and Diagnostics Product Offered
Table 68. Johnson & Johnson Main Business
Table 69. Johnson & Johnson Gastrointestinal Therapeutics and Diagnostics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. Johnson & Johnson Latest Developments
Table 71. Salix Pharmaceuticals Details, Company Type, Gastrointestinal Therapeutics and Diagnostics Area Served and Its Competitors
Table 72. Salix Pharmaceuticals Gastrointestinal Therapeutics and Diagnostics Product Offered
Table 73. Salix Pharmaceuticals Main Business
Table 74. Salix Pharmaceuticals Gastrointestinal Therapeutics and Diagnostics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. Salix Pharmaceuticals Latest Developments
Table 76. Takeda Pharmaceutical Company Details, Company Type, Gastrointestinal Therapeutics and Diagnostics Area Served and Its Competitors
Table 77. Takeda Pharmaceutical Company Gastrointestinal Therapeutics and Diagnostics Product Offered
Table 78. Takeda Pharmaceutical Company Main Business
Table 79. Takeda Pharmaceutical Company Gastrointestinal Therapeutics and Diagnostics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. Takeda Pharmaceutical Company Latest Developments
LIST OF FIGURES
Figure 1. Gastrointestinal Therapeutics and Diagnostics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Gastrointestinal Therapeutics and Diagnostics Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Gastrointestinal Therapeutics and Diagnostics Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Gastrointestinal Therapeutics and Diagnostics Sales Market Share by Country/Region (2022)
Figure 8. Gastrointestinal Therapeutics and Diagnostics Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Type in 2022
Figure 10. Gastrointestinal Therapeutics and Diagnostics in Gastroenteritis
Figure 11. Global Gastrointestinal Therapeutics and Diagnostics Market: Gastroenteritis (2018-2023) & ($ Millions)
Figure 12. Gastrointestinal Therapeutics and Diagnostics in GI Bleeding
Figure 13. Global Gastrointestinal Therapeutics and Diagnostics Market: GI Bleeding (2018-2023) & ($ Millions)
Figure 14. Gastrointestinal Therapeutics and Diagnostics in Irritable Bowel Syndrome
Figure 15. Global Gastrointestinal Therapeutics and Diagnostics Market: Irritable Bowel Syndrome (2018-2023) & ($ Millions)
Figure 16. Gastrointestinal Therapeutics and Diagnostics in Peptic Ulcer Disease (PUD)
Figure 17. Global Gastrointestinal Therapeutics and Diagnostics Market: Peptic Ulcer Disease (PUD) (2018-2023) & ($ Millions)
Figure 18. Gastrointestinal Therapeutics and Diagnostics in Others
Figure 19. Global Gastrointestinal Therapeutics and Diagnostics Market: Others (2018-2023) & ($ Millions)
Figure 20. Global Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Application in 2022
Figure 21. Global Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Player in 2022
Figure 22. Global Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Regions (2018-2023)
Figure 23. Americas Gastrointestinal Therapeutics and Diagnostics Market Size 2018-2023 ($ Millions)
Figure 24. APAC Gastrointestinal Therapeutics and Diagnostics Market Size 2018-2023 ($ Millions)
Figure 25. Europe Gastrointestinal Therapeutics and Diagnostics Market Size 2018-2023 ($ Millions)
Figure 26. Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size 2018-2023 ($ Millions)
Figure 27. Americas Gastrointestinal Therapeutics and Diagnostics Value Market Share by Country in 2022
Figure 28. United States Gastrointestinal Therapeutics and Diagnostics Market Size Growth 2018-2023 ($ Millions)
Figure 29. Canada Gastrointestinal Therapeutics and Diagnostics Market Size Growth 2018-2023 ($ Millions)
Figure 30. Mexico Gastrointestinal Therapeutics and Diagnostics Market Size Growth 2018-2023 ($ Millions)
Figure 31. Brazil Gastrointestinal Therapeutics and Diagnostics Market Size Growth 2018-2023 ($ Millions)
Figure 32. APAC Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Region in 2022
Figure 33. APAC Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Type in 2022
Figure 34. APAC Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Application in 2022
Figure 35. China Gastrointestinal Therapeutics and Diagnostics Market Size Growth 2018-2023 ($ Millions)
Figure 36. Japan Gastrointestinal Therapeutics and Diagnostics Market Size Growth 2018-2023 ($ Millions)
Figure 37. Korea Gastrointestinal Therapeutics and Diagnostics Market Size Growth 2018-2023 ($ Millions)
Figure 38. Southeast Asia Gastrointestinal Therapeutics and Diagnostics Market Size Growth 2018-2023 ($ Millions)
Figure 39. India Gastrointestinal Therapeutics and Diagnostics Market Size Growth 2018-2023 ($ Millions)
Figure 40. Australia Gastrointestinal Therapeutics and Diagnostics Market Size Growth 2018-2023 ($ Millions)
Figure 41. Europe Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Country in 2022
Figure 42. Europe Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Type (2018-2023)
Figure 43. Europe Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Application (2018-2023)
Figure 44. Germany Gastrointestinal Therapeutics and Diagnostics Market Size Growth 2018-2023 ($ Millions)
Figure 45. France Gastrointestinal Therapeutics and Diagnostics Market Size Growth 2018-2023 ($ Millions)
Figure 46. UK Gastrointestinal Therapeutics and Diagnostics Market Size Growth 2018-2023 ($ Millions)
Figure 47. Italy Gastrointestinal Therapeutics and Diagnostics Market Size Growth 2018-2023 ($ Millions)
Figure 48. Russia Gastrointestinal Therapeutics and Diagnostics Market Size Growth 2018-2023 ($ Millions)
Figure 49. Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Region (2018-2023)
Figure 50. Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Type (2018-2023)
Figure 51. Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Application (2018-2023)
Figure 52. Egypt Gastrointestinal Therapeutics and Diagnostics Market Size Growth 2018-2023 ($ Millions)
Figure 53. South Africa Gastrointestinal Therapeutics and Diagnostics Market Size Growth 2018-2023 ($ Millions)
Figure 54. Israel Gastrointestinal Therapeutics and Diagnostics Market Size Growth 2018-2023 ($ Millions)
Figure 55. Turkey Gastrointestinal Therapeutics and Diagnostics Market Size Growth 2018-2023 ($ Millions)
Figure 56. GCC Country Gastrointestinal Therapeutics and Diagnostics Market Size Growth 2018-2023 ($ Millions)
Figure 57. Americas Gastrointestinal Therapeutics and Diagnostics Market Size 2024-2029 ($ Millions)
Figure 58. APAC Gastrointestinal Therapeutics and Diagnostics Market Size 2024-2029 ($ Millions)
Figure 59. Europe Gastrointestinal Therapeutics and Diagnostics Market Size 2024-2029 ($ Millions)
Figure 60. Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size 2024-2029 ($ Millions)
Figure 61. United States Gastrointestinal Therapeutics and Diagnostics Market Size 2024-2029 ($ Millions)
Figure 62. Canada Gastrointestinal Therapeutics and Diagnostics Market Size 2024-2029 ($ Millions)
Figure 63. Mexico Gastrointestinal Therapeutics and Diagnostics Market Size 2024-2029 ($ Millions)
Figure 64. Brazil Gastrointestinal Therapeutics and Diagnostics Market Size 2024-2029 ($ Millions)
Figure 65. China Gastrointestinal Therapeutics and Diagnostics Market Size 2024-2029 ($ Millions)
Figure 66. Japan Gastrointestinal Therapeutics and Diagnostics Market Size 2024-2029 ($ Millions)
Figure 67. Korea Gastrointestinal Therapeutics and Diagnostics Market Size 2024-2029 ($ Millions)
Figure 68. Southeast Asia Gastrointestinal Therapeutics and Diagnostics Market Size 2024-2029 ($ Millions)
Figure 69. India Gastrointestinal Therapeutics and Diagnostics Market Size 2024-2029 ($ Millions)
Figure 70. Australia Gastrointestinal Therapeutics and Diagnostics Market Size 2024-2029 ($ Millions)
Figure 71. Germany Gastrointestinal Therapeutics and Diagnostics Market Size 2024-2029 ($ Millions)
Figure 72. France Gastrointestinal Therapeutics and Diagnostics Market Size 2024-2029 ($ Millions)
Figure 73. UK Gastrointestinal Therapeutics and Diagnostics Market Size 2024-2029 ($ Millions)
Figure 74. Italy Gastrointestinal Therapeutics and Diagnostics Market Size 2024-2029 ($ Millions)
Figure 75. Russia Gastrointestinal Therapeutics and Diagnostics Market Size 2024-2029 ($ Millions)
Figure 76. Spain Gastrointestinal Therapeutics and Diagnostics Market Size 2024-2029 ($ Millions)
Figure 77. Egypt Gastrointestinal Therapeutics and Diagnostics Market Size 2024-2029 ($ Millions)
Figure 78. South Africa Gastrointestinal Therapeutics and Diagnostics Market Size 2024-2029 ($ Millions)
Figure 79. Israel Gastrointestinal Therapeutics and Diagnostics Market Size 2024-2029 ($ Millions)
Figure 80. Turkey Gastrointestinal Therapeutics and Diagnostics Market Size 2024-2029 ($ Millions)
Figure 81. GCC Countries Gastrointestinal Therapeutics and Diagnostics Market Size 2024-2029 ($ Millions)
Figure 82. Global Gastrointestinal Therapeutics and Diagnostics Market Size Market Share Forecast by Type (2024-2029)
Figure 83. Global Gastrointestinal Therapeutics and Diagnostics Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Gastrointestinal Therapeutics and Diagnostics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Gastrointestinal Therapeutics and Diagnostics Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Gastrointestinal Therapeutics and Diagnostics Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Gastrointestinal Therapeutics and Diagnostics Sales Market Share by Country/Region (2022)
Figure 8. Gastrointestinal Therapeutics and Diagnostics Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Type in 2022
Figure 10. Gastrointestinal Therapeutics and Diagnostics in Gastroenteritis
Figure 11. Global Gastrointestinal Therapeutics and Diagnostics Market: Gastroenteritis (2018-2023) & ($ Millions)
Figure 12. Gastrointestinal Therapeutics and Diagnostics in GI Bleeding
Figure 13. Global Gastrointestinal Therapeutics and Diagnostics Market: GI Bleeding (2018-2023) & ($ Millions)
Figure 14. Gastrointestinal Therapeutics and Diagnostics in Irritable Bowel Syndrome
Figure 15. Global Gastrointestinal Therapeutics and Diagnostics Market: Irritable Bowel Syndrome (2018-2023) & ($ Millions)
Figure 16. Gastrointestinal Therapeutics and Diagnostics in Peptic Ulcer Disease (PUD)
Figure 17. Global Gastrointestinal Therapeutics and Diagnostics Market: Peptic Ulcer Disease (PUD) (2018-2023) & ($ Millions)
Figure 18. Gastrointestinal Therapeutics and Diagnostics in Others
Figure 19. Global Gastrointestinal Therapeutics and Diagnostics Market: Others (2018-2023) & ($ Millions)
Figure 20. Global Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Application in 2022
Figure 21. Global Gastrointestinal Therapeutics and Diagnostics Revenue Market Share by Player in 2022
Figure 22. Global Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Regions (2018-2023)
Figure 23. Americas Gastrointestinal Therapeutics and Diagnostics Market Size 2018-2023 ($ Millions)
Figure 24. APAC Gastrointestinal Therapeutics and Diagnostics Market Size 2018-2023 ($ Millions)
Figure 25. Europe Gastrointestinal Therapeutics and Diagnostics Market Size 2018-2023 ($ Millions)
Figure 26. Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size 2018-2023 ($ Millions)
Figure 27. Americas Gastrointestinal Therapeutics and Diagnostics Value Market Share by Country in 2022
Figure 28. United States Gastrointestinal Therapeutics and Diagnostics Market Size Growth 2018-2023 ($ Millions)
Figure 29. Canada Gastrointestinal Therapeutics and Diagnostics Market Size Growth 2018-2023 ($ Millions)
Figure 30. Mexico Gastrointestinal Therapeutics and Diagnostics Market Size Growth 2018-2023 ($ Millions)
Figure 31. Brazil Gastrointestinal Therapeutics and Diagnostics Market Size Growth 2018-2023 ($ Millions)
Figure 32. APAC Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Region in 2022
Figure 33. APAC Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Type in 2022
Figure 34. APAC Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Application in 2022
Figure 35. China Gastrointestinal Therapeutics and Diagnostics Market Size Growth 2018-2023 ($ Millions)
Figure 36. Japan Gastrointestinal Therapeutics and Diagnostics Market Size Growth 2018-2023 ($ Millions)
Figure 37. Korea Gastrointestinal Therapeutics and Diagnostics Market Size Growth 2018-2023 ($ Millions)
Figure 38. Southeast Asia Gastrointestinal Therapeutics and Diagnostics Market Size Growth 2018-2023 ($ Millions)
Figure 39. India Gastrointestinal Therapeutics and Diagnostics Market Size Growth 2018-2023 ($ Millions)
Figure 40. Australia Gastrointestinal Therapeutics and Diagnostics Market Size Growth 2018-2023 ($ Millions)
Figure 41. Europe Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Country in 2022
Figure 42. Europe Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Type (2018-2023)
Figure 43. Europe Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Application (2018-2023)
Figure 44. Germany Gastrointestinal Therapeutics and Diagnostics Market Size Growth 2018-2023 ($ Millions)
Figure 45. France Gastrointestinal Therapeutics and Diagnostics Market Size Growth 2018-2023 ($ Millions)
Figure 46. UK Gastrointestinal Therapeutics and Diagnostics Market Size Growth 2018-2023 ($ Millions)
Figure 47. Italy Gastrointestinal Therapeutics and Diagnostics Market Size Growth 2018-2023 ($ Millions)
Figure 48. Russia Gastrointestinal Therapeutics and Diagnostics Market Size Growth 2018-2023 ($ Millions)
Figure 49. Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Region (2018-2023)
Figure 50. Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Type (2018-2023)
Figure 51. Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size Market Share by Application (2018-2023)
Figure 52. Egypt Gastrointestinal Therapeutics and Diagnostics Market Size Growth 2018-2023 ($ Millions)
Figure 53. South Africa Gastrointestinal Therapeutics and Diagnostics Market Size Growth 2018-2023 ($ Millions)
Figure 54. Israel Gastrointestinal Therapeutics and Diagnostics Market Size Growth 2018-2023 ($ Millions)
Figure 55. Turkey Gastrointestinal Therapeutics and Diagnostics Market Size Growth 2018-2023 ($ Millions)
Figure 56. GCC Country Gastrointestinal Therapeutics and Diagnostics Market Size Growth 2018-2023 ($ Millions)
Figure 57. Americas Gastrointestinal Therapeutics and Diagnostics Market Size 2024-2029 ($ Millions)
Figure 58. APAC Gastrointestinal Therapeutics and Diagnostics Market Size 2024-2029 ($ Millions)
Figure 59. Europe Gastrointestinal Therapeutics and Diagnostics Market Size 2024-2029 ($ Millions)
Figure 60. Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Market Size 2024-2029 ($ Millions)
Figure 61. United States Gastrointestinal Therapeutics and Diagnostics Market Size 2024-2029 ($ Millions)
Figure 62. Canada Gastrointestinal Therapeutics and Diagnostics Market Size 2024-2029 ($ Millions)
Figure 63. Mexico Gastrointestinal Therapeutics and Diagnostics Market Size 2024-2029 ($ Millions)
Figure 64. Brazil Gastrointestinal Therapeutics and Diagnostics Market Size 2024-2029 ($ Millions)
Figure 65. China Gastrointestinal Therapeutics and Diagnostics Market Size 2024-2029 ($ Millions)
Figure 66. Japan Gastrointestinal Therapeutics and Diagnostics Market Size 2024-2029 ($ Millions)
Figure 67. Korea Gastrointestinal Therapeutics and Diagnostics Market Size 2024-2029 ($ Millions)
Figure 68. Southeast Asia Gastrointestinal Therapeutics and Diagnostics Market Size 2024-2029 ($ Millions)
Figure 69. India Gastrointestinal Therapeutics and Diagnostics Market Size 2024-2029 ($ Millions)
Figure 70. Australia Gastrointestinal Therapeutics and Diagnostics Market Size 2024-2029 ($ Millions)
Figure 71. Germany Gastrointestinal Therapeutics and Diagnostics Market Size 2024-2029 ($ Millions)
Figure 72. France Gastrointestinal Therapeutics and Diagnostics Market Size 2024-2029 ($ Millions)
Figure 73. UK Gastrointestinal Therapeutics and Diagnostics Market Size 2024-2029 ($ Millions)
Figure 74. Italy Gastrointestinal Therapeutics and Diagnostics Market Size 2024-2029 ($ Millions)
Figure 75. Russia Gastrointestinal Therapeutics and Diagnostics Market Size 2024-2029 ($ Millions)
Figure 76. Spain Gastrointestinal Therapeutics and Diagnostics Market Size 2024-2029 ($ Millions)
Figure 77. Egypt Gastrointestinal Therapeutics and Diagnostics Market Size 2024-2029 ($ Millions)
Figure 78. South Africa Gastrointestinal Therapeutics and Diagnostics Market Size 2024-2029 ($ Millions)
Figure 79. Israel Gastrointestinal Therapeutics and Diagnostics Market Size 2024-2029 ($ Millions)
Figure 80. Turkey Gastrointestinal Therapeutics and Diagnostics Market Size 2024-2029 ($ Millions)
Figure 81. GCC Countries Gastrointestinal Therapeutics and Diagnostics Market Size 2024-2029 ($ Millions)
Figure 82. Global Gastrointestinal Therapeutics and Diagnostics Market Size Market Share Forecast by Type (2024-2029)
Figure 83. Global Gastrointestinal Therapeutics and Diagnostics Market Size Market Share Forecast by Application (2024-2029)
